Outcome of Vital Pulp Therapy Using MTA and Biodentine in Permanent First Molars with or without Pulpitis in Pediatric Patients

Authors

Daniel Nho DMD, MS, Private PracticeFollow
Susan Paurazas DDS, MS, MHSA, University of Detroit Mercy School of DentistryFollow
Mazin Askar BDS, MS, University of Detroit Mercy School of DentistryFollow
Salwa Atwan DDS, MS, University of Detroit Mercy School of DentistryFollow

Abstract

Purpose: This study evaluated the outcome of vital pulp therapy (VPT) in permanent first molar teeth using Biodentine (Septodont, Saint Maur des Fosses, France) or ProRoot MTA (Dentsply Tulsa Dental Specialties, Johnson City, Tenn.) in pediatric patients. Methods: Permanent first molar teeth with or without a history of pulpitis from patients aged 7 to 14 years old were treated at the Graduate Endodontic Clinic from September 2007 to August 2022. A retrospective cohort clinical trial was conducted. VPT was performed on a total of 22 teeth. There were 13 teeth in the Biodentine (BD) group and nine teeth in the ProRoot MTA (MTA) group. All teeth were examined clinically and radiographically to determine the health status of the pulp and periapical tissues. Results: Of the 22 teeth, 16 teeth were present in the mouth, five teeth have been extracted and one tooth had only root tips. The Biodentine group had 69.2% of teeth that were vital. The ProRoot MTA group had 55.6% of teeth that were vital. The average follow-up period was 62.3 months for the Biodentine group and 91.2 months for ProRoot MTA group. Teeth with immature permanent roots showed continued or complete root development radiographically at follow-up examination. Conclusions: VPT in permanent first molar teeth using either Biodentine or ProRoot MTA in pediatric patients has a successful outcome and can be considered as a reliable treatment modality for maintaining pulp vitality and observing continued root development.

Recommended Citation

Nho, Daniel DMD, MS; Paurazas, Susan DDS, MS, MHSA; Askar, Mazin BDS, MS; and Atwan, Salwa DDS, MS (2024) "Outcome of Vital Pulp Therapy Using MTA and Biodentine in Permanent First Molars with or without Pulpitis in Pediatric Patients," The Journal of the Michigan Dental Association: Vol. 106: No. 10, Article 4.
Available at: https://commons.ada.org/journalmichigandentalassociation/vol106/iss10/4